Avient Corporation
NYSE:AVNTChemicals - Specialty
+$0.04 today
- Market cap
- $4.07B
- Beta
- 1.30
- P/E (TTM)
- 21.4
- EPS (TTM)
- $1.72
- Dividend yield
- 2.97%
Volume 0.55M
Average 0.74M
AVNT Sales of Investments
Cash received from selling or redeeming investments.
Avient CorporationNYSE: AVNT
Sales of Investments · Q3 FY2026 · quarter ended Sep 2026
Sales of investments outflow grows to $0
Q3 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $0.
Context
- Sales of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Sales of investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Sales of Investments vs competitors
How AVNT compares with its peers on the latest reported figures
- AVNT's LTM Sep 2026 sales of investments of $0 is the 3rd largest of the 11 companies compared; the peer median is $0.
- Sales of investments amounts to 0.0% of revenue for AVNT, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $86M | +72.0% | +10.7% | 4.7% | |
| LTM Jun 2026 | $9.63M | -80.7% | — | 0.2% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | +100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AVNT) | $0 | +72.0% | +10.7% | 0.0% | |
Competitors are the stored peer set for AVNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 230.6M | 703.4M | 76.2M | 170.7M | 83.6M |
| Depreciation & Amortization | 145.9M | 163.1M | 188.8M | 179.7M | 185.9M |
| Deferred Income Tax | (27.3M) | 500K | (61.3M) | (23.8M) | (45.4M) |
| Stock-Based Compensation | 11.2M | 13.2M | 13.2M | 15.4M | 9.1M |
| Change in Working Capital | (128.1M) | 36.7M | 88.8M | (51.2M) | (3.2M) |
| Accounts Receivables | (143.1M) | 32.6M | 38.6M | (15.2M) | (18.3M) |
| Inventory | (141M) | 14M | 24.3M | (13.7M) | 600K |
| Accounts Payables | 95.3M | 10.7M | (22.2M) | 300K | (27.6M) |
| Other Working Capital | 60.7M | (20.6M) | 48.1M | (22.6M) | 42.1M |
| Other Non-Cash Items | 1.5M | (518.5M) | (104.1M) | (34M) | 71.6M |
| Operating Cash Flow | 233.8M | 398.4M | 201.6M | 256.8M | 301.6M |
| Capital Expenditures | (100.6M) | (105.5M) | (119.4M) | (121.9M) | (106.6M) |
| Acquisitions (Net) | (47.6M) | (497.9M) | 7.3M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (2M) | 99.4M | 17.9M | 1.3M | 9.6M |
| Investing Cash Flow | (150.2M) | (504M) | (94.2M) | (120.6M) | (97M) |
| Debt Repayment | (18.5M) | 343.2M | (105.8M) | (10.9M) | (150.3M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (4.2M) | (36.4M) | (3.4M) | (6.4M) | (4.1M) |
| Dividends Paid | (77.7M) | (86.8M) | (90.2M) | (94M) | (98.8M) |
| Other Financing Activities | (14.2M) | (53.6M) | (2.3M) | (9.6M) | (3.9M) |
| Financing Cash Flow | (114.6M) | 166.4M | (201.7M) | (120.9M) | (257.1M) |
| Effect of Forex Changes | (17.3M) | (20.9M) | (1M) | (16.6M) | 18.5M |
| Net Change in Cash | (48.3M) | 39.9M | (95.3M) | (1.3M) | (34M) |
| Free Cash Flow | 133.2M | 292.9M | 82.2M | 134.9M | 195M |
Avient Corporation
NYSE:AVNT
Intrinsic Alpha fair value
Locked
Current Price
$44.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.